Ahmed-Lecheheb, D., & Joly, F. (2016). Ovarian cancer survivors’ quality of life: a systematic review. Journal of Cancer Survivorship, 10(5), 789–801. https://doi.org/10.1007/s11764-016-0525-8
Asante, A., Leonard, P. H., Weaver, A. L., Goode, E. L., Jensen, J. R., Stewart, E. A., & Coddington, C. C. (2013). Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study. Fertility and Sterility, 99(7), 2031–2036. https://doi.org/10.1016/j.fertnstert.2013.02.010
Aziz, M. F., Andrijono, & Saifuddin, A. B. (2006). Buku Acuan Nasional Onkologi Ginekologi (M. F. Aziz, Andrijono, & A. B. Saifuddin (eds.); 1st ed.). Yayasan Bina Pustaka Sarwono Prawirohardjo.
Babic, A., Cramer, D. W., Titus, L. J., Tworoger, S. S., & Terry, K. L. (2014). Menstrual pain and epithelial ovarian cancer risk. Cancer Causes and Control, 25(12), 1725–1731. https://doi.org/10.1007/s10552-014-0463-6
Berek, J. S. (2012). Berek & Novak’s Gynecology (Fifteenth). Lippincott Williams & Wilkins.
Bethea, T. N., Palmer, J. R., Adams-Campbell, L. L., & Rosenberg, L. (2017). A prospective study of reproductive factors and exogenous hormone use about ovarian cancer risk among Black women. Cancer Causes and Control, 28(5), 385–391. https://doi.org/10.1007/s10552-016-0840-4
Bobak. (n.d.). Buku Ajar Keperawatan Maternitas.
Burghaus, S., Häberle, L., Schrauder, M. G., Heusinger, K., Thiel, F. C., Hein, A., Wachter, D., Strehl, J., Hartmann, A., Ekici, A. B., Renner, S. P., Beckmann, M. W., & Fasching, P. A. (2015). Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study. BMC Cancer, 15, 751. https://doi.org/10.1186/s12885-015-1821-9
Cress, R. D., Chen, Y. S., Morris, C. R., Petersen, M., & Leiserowitz, G. S. (2015). Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstetrics and Gynecology, 126(3), 491–497. https://doi.org/10.1097/AOG.0000000000000981
Ebell, M. H., Culp, M. B., & Radke, T. J. (2016). A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer. American Journal of Preventive Medicine, 50(3), 384–394. https://doi.org/10.1016/j.amepre.2015.09.023
Fischer, O. J., Marguerie, M., & Brotto, L. A. (2019). Sexual Function, Quality of Life, and Experiences of Women with Ovarian Cancer: A Mixed-Methods Study. Sexual Medicine, 7(4), 530–539. https://doi.org/10.1016/j.esxm.2019.07.005
Gea, I. T., Loho, M. F., & Wagey, F. W. (2016). Gambaran jenis kanker ovarium di RSUP Prof. Dr. R. D. Kandou Manado. Journal E-Clinic, 4(2), 2–6.
Guleria, S., Jensen, A., Toender, A., & Kjaer, S. K. (2020). Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study. Cancer Causes and Control, 31(1), 25–31. https://doi.org/10.1007/s10552-019-01245-4
Hamid Prasetya Subagja. (2014). Kanker- Kanker Ganas Pembunuh Wanita (Hira (ed.)).
He, Z.-X., Shi, H.-H., Fan, Q.-B., Zhu, L., Leng, J.-H., Sun, D.-W., Li, Z.-F., Shen, K., Wang, S., & Lang, J.-H. (2017). Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China. Journal of Ovarian Research, 10(1), 45. https://doi.org/10.1186/s13048-017-0343-2
Hughes, K. S., Roche, C., Campbell, C. T., Siegel, N., Salisbury, L., Chekos, A., Katz, M. S., & Edell, E. (2003). Prevalence of a family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. The Breast Journal, 9(1), 19–25. https://doi.org/10.1046/j.1524-4741.2003.09105.x
Inci, M. G., Richter, R., Heise, K., Dukatz, R., Woopen, H., & Sehouli, J. (2021). Patient-reported outcomes (Pros) and health-related quality of life (hr-qol) in patients with ovarian cancer: What is different for healthy women? Cancers, 13(4), 1–11. https://doi.org/10.3390/cancers13040631
Indriani, R., Amarullah Ritonga, M., & Suardi, D. (2018). Evaluasi tindakan operatif pada kanker serviks, endometrium, dan ovarium di RSUP Dr. Hasan Sadikin Bandung tahun 2015-2016. Indonesian Journal of Obstetrics & Gynecology Science, 1(2), 79–86. https://doi.org/10.24198/obgynia.v1n2.49
Le, D. C., Kubo, T., Fujino, Y., Sokal, D. C., Vach, T. H., Pham, T. M., & Matsuda, S. (2012). Reproductive factors about ovarian cancer: A case-control study in Northern Vietnam. Contraception, 86(5), 494–499. https://doi.org/10.1016/j.contraception.2012.02.019
Lee, A. H., Su, D., Pasalich, M., & Binns, C. W. (2013). Preserved foods are associated with an increased risk of ovarian cancer. Gynecologic Oncology, 129(3), 570–573. https://doi.org/10.1016/j.ygyno.2013.03.016
Li et al. (2015). Passive Smoking and Ovarian Cancer Risk among Non-Smoking Women: A Licaj, I., Lukic, M., Jareid, M., Lund, E., Braaten, T., & Gram, I. T. (2016). Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012. Cancer Medicine, 5(4), 720–727. https://doi.org/10.1002/cam4.590
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies Evaluating Health Care Interventions : Explanation and Elaboration. Plos Medicine, 6(7). https://doi.org/10.1371/journal.pmed.1000100
Licaj, I., Lukic, M., Jareid, M., Lund, E., Braaten, T., & Gram, I. T. (2016). Epithelial ovarian cancer subtypes were attributable to smoking in the Norwegian Women and Cancer Study, 2012. Cancer Medicine, 5(4), 720–727. https://doi.org/10.1002/cam4.590
Liu, Y. L., Filippova, O. T., Zhou, Q., Iasonos, A., Chi, D. S., Zivanovic, O., Sonoda, Y., Gardner, G. J., Broach, V. A., Cearbhaill, R. E. O., Konner, J. A., Aghajanian, C., Roche, K. L., & Tew, W. P. (2020). Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of Gynecologic Oncology, 31(1), 1–12.
Lisnawati. (2013). Gambaran Faktor-Faktor Risiko Penderita Kanker Ovarium di RSUD. http://repositori.uin-alauddin.ac.id/.
Lundberg, F. E., Johansson, A. L. V, Rodriguez-Wallberg, K., Gemzell-Danielsson, K., & Iliadou, A. N. (2019). Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. European Journal of Epidemiology, 34(11), 1093–1101. https://doi.org/10.1007/s10654-019-00540-3
Mayer, S., Iborra, S., Grimm, D., Steinsiek, L., Mahner, S., Bossart, M., Woelber, L., Voss, P. J., Gitsch, G., & Hasenburg, A. (2019). Sexual activity and quality of life in patients after breast and ovarian cancer treatment. Archives of Gynecology and Obstetrics, 299(1), 191–201. https://doi.org/10.1007/s00404-018-4922-2
Mori, M., & Miyake, H. (1988). Dietary and other risk factors of ovarian cancer among elderly women. Japanese Journal of Cancer Research : Gann, 79(9), 997–1004. https://doi.org/10.1111/j.1349-7006.1988.tb00066.x
Momenimovahed. (2019). Ovarian cancer in the world: Epidemiology and risk factors. International Journal of Women’s Health, 11, 287–299. https://doi.org/10.2147/IJWH.S197604.
Nurrika. (2020). Analisis Ketahanan Hidup Lima Tahun Penderita Kanker. Jurnal Kesehatan Masyarakat Nasional Vol. 5, No. 3, https://www.neliti.com/publications/39757/.
Pięta, B., Chmaj-Wierzchowska, K., & Opala, T. (2012). Past obstetric history and risk of ovarian cancer. Annals of Agricultural and Environmental Medicine : AAEM, 19(3), 385–388.
Prawirohardjo. (2010). Buku panduan Praktis Pelayanan Kesehatan Maternal dan. Neonatal.
Ratnawati, A. (2018). Sistem Reproduksi. Pustaka Baru Press.
Rietveld, M. J. A., Husson, O., Vos, M. C. (Caroline., van de Poll-
Franse, L. V., Ottevanger, P. B. (Nelleke., & Ezendam, N. P. M. (2019). Presence of gastrointestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry. Supportive Care in Cancer, 27(6), 2285–2293. https://doi.org/10.1007/s00520-018-4510-9
Rock and Jhon, (2008). Te Linde’s Operative Gynecology, ed 10 th Philadelphia : Lippincott Williams & Wilkins.
Rosida, S., Sanif, R., Novaliani, A., & Theodorus. (2020). Efektivitas kemoterapi kombinasi paklitaksel – karboplatin berdasarkan kadar vascular endothelial growth factor A ( VEGF-A ) serum pada kanker ovarium tipe epitel. Jurnal Kedokteran Dan Kesehatan, 7(2), 91–98.
Shields et al. (2014). A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus. Cancer Epidemiol Biomarker, 13(10), pp. 1574–1582.
Utami. (2016). Efektifitas latihan Progressive Muscle Relaxation (PMR) terhadap mual. Jurnal Keperawatan Jiwa, Volume 4 No 2, Hal 83 - 90, November 2016.
World Health Organization. (2019). Indonesia Source GLOBOCAN 2018. International Agency for Research on Cancer,. 256, 1–2. http://gco.iarc.fr/.
Wulandari, M. R. S. (2018). Kecemasan dan kualitas pada penderita kanker ovarium. Caring, 2(2), 1–7.